Cargando…
Troxerutin protects against diabetic cardiomyopathy through NF-κB/AKT/IRS1 in a rat model of type 2 diabetes
Troxerutin is a bioflavonoid, which can be used to treat venous disorders, thrombosis and cerebrovascular diseases. Recent studies have demonstrated that it may also be used to prevent edemas. However, it is not known whether troxerutin protects against the cardiomyopathic complications of diabetes....
Autores principales: | Yu, Yongzhi, Zheng, Guanzhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436284/ https://www.ncbi.nlm.nih.gov/pubmed/28440404 http://dx.doi.org/10.3892/mmr.2017.6456 |
Ejemplares similares
-
Troxerutin protects against DHT-induced polycystic ovary syndrome in rats
por: Gao, Zixuan, et al.
Publicado: (2020) -
Correction to: Troxerutin protects against DHT-induced polycystic ovary syndrome in rats
por: Gao, Zixuan, et al.
Publicado: (2020) -
Effects of troxerutin on vascular inflammatory mediators and expression of microRNA-146a/NF-κB signaling pathway in aorta of healthy and diabetic rats
por: Xing, Che, et al.
Publicado: (2020) -
Troxerutin affects the male fertility in prepubertal type 1 diabetic male rats
por: Zavvari Oskuye, Zohreh, et al.
Publicado: (2019) -
Troxerutin affects nephropathy signaling events in the kidney of type-1 diabetic male rats
por: Keyhanmanesh, Rana, et al.
Publicado: (2022)